No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Lake Street Maintains LifeMD(LFMD.US) With Buy Rating, Maintains Target Price $12
Mizuho Securities Maintains LifeMD(LFMD.US) With Hold Rating
Mizuho Securities Sticks to Its Hold Rating for LifeMD (LFMD)
Lake Street Initiates LifeMD(LFMD.US) With Buy Rating, Announces Target Price $12
This Insider Has Just Sold Shares In LifeMD
Medifast Survey Finds Majority of U.S. Adults Trying to Lose Weight Agree Lifestyle Changes Are Essential – Even With Weight Loss Medications
No Data